BRIEF-National Institutes Of Health Begins Clini
Post# of 716
(Total Views: 230)
Posted On: 05/14/2020 2:29:18 PM
BRIEF-National Institutes Of Health Begins Clinical Trial Of Hydroxychloroquine And Azithromycin To Treat Covid-19
BY Reuters
— 2:16 PM ET 05/14/2020
May 14 (Reuters) - National Institutes Of Health:
* NATIONAL INSTITUTES OF HEALTH BEGINS CLINICAL TRIAL OF HYDROXYCHLOROQUINE AND AZITHROMYCIN TO TREAT COVID-19
* TEVA PHARMACEUTICALS IS DONATING MEDICATIONS FOR PHASE 2B STUDY ENROLLING ADULTS WITH MILD TO MODERATE COVID-19 IN U.S.
* PHASE 2B TRIAL WILL ENROLL APPROXIMATELY 2,000 ADULTS AT PARTICIPATING AIDS CLINICAL TRIALS GROUP
* PARTICIPANTS IN ACTG STUDY, CALLED A5395, WILL RECEIVE ORAL MEDICATIONS TO TAKE AT HOME
* PARTICIPANTS WILL RECORD THEIR SYMPTOMS, ADHERENCE TO TREATMENT, AND MAJOR EVENTS SUCH AS HOSPITALIZATIONS IN A DIARY FOR 20 DAYS
* PARTICIPANTS RANDOMLY ASSIGNED TO EXPERIMENTAL GROUP WILL TAKE 400 MG OF HYDROXYCHLOROQUINE TWICE ON DAY 1, 200 MG TWICE DAILY FOR ADDED 6 DAYS Source text : (https://bit.ly/2Z2Evov)
(1)
(0)